These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6618347)
41. [Diverse action of 17-alpha-hydroxyprogesterone caproate and medroxyprogesterone acetate on the biosynthesis of collagen and cirrhogenous course of CC14-induced hepatic lesions in rats]. Gambella GR; Burlando F; Vascotto E; Novelli A Arch Sci Med (Torino); 1983; 140(4):413-6. PubMed ID: 6231903 [TBL] [Abstract][Full Text] [Related]
42. Comparison of ballooned hepatocytes in alcoholic and non-alcoholic liver injury in rats. Matsuda Y; Takase S; Takada A; Sato H; Yasuhara M Alcohol; 1985; 2(2):303-8. PubMed ID: 4015851 [TBL] [Abstract][Full Text] [Related]
43. Txn1, Ctsd and Cdk4 are key proteins of combination therapy with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats. Cao W; Li Y; Li M; Zhang X; Liao M Biomed Pharmacother; 2017 Jan; 85():611-619. PubMed ID: 27894668 [TBL] [Abstract][Full Text] [Related]
44. Lymphatic role in the pathogenesis of fat malabsorption in liver cirrhosis in rats. Miura S; Asakura H; Munakata Y; Kobayashi K; Yoshioka M; Morishita T; Tsuchiya M Dig Dis Sci; 1982 Nov; 27(11):1030-6. PubMed ID: 7140488 [TBL] [Abstract][Full Text] [Related]
45. A clinical and experimental study of the effects of some anabolic steroids on hepatic structure and function. Perezagua-Clamagirand C; Portugal-Alvarez J; Velasco-Martín A Arch Farmacol Toxicol; 1975 Mar; 1(1):77-82. PubMed ID: 1217922 [No Abstract] [Full Text] [Related]
46. Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl Yan J; Feng Y; Fang X; Cui X; Xia X; Li F; Luo W; Liang J; Feng J; Yu K Pharm Biol; 2022 Dec; 60(1):1264-1277. PubMed ID: 35787093 [TBL] [Abstract][Full Text] [Related]
48. Experimental toxic cirrhosis in the rat. Kinetics of hepatocyte proliferation during intermittent carbon tetrachloride intoxication. Shea SM Exp Mol Pathol; 1966 Jun; 5(3):311-28. PubMed ID: 5914661 [No Abstract] [Full Text] [Related]
49. Use of hepatoprotective drugs in leprosy treatment. Bergel M Nihon Rai Gakkai Zasshi; 1983; 52(1):62-3. PubMed ID: 6678924 [No Abstract] [Full Text] [Related]
50. [Changes in the basic parameters of glycide metabolism during liver regeneration following liver cirrhosis induced by continuous carbon tetrachloride administration to rabbits]. Javorský A; Dibák O; Kossey P Bratisl Lek Listy; 1966 Sep; 46(5):266-74. PubMed ID: 6010234 [No Abstract] [Full Text] [Related]
51. Sequential histopathologic alterations in Indian childhood cirrhosis treated with d-penicillamine. Bhusnurmath SR; Walia BN; Singh S; Parkash D; Radotra BD; Nath R Hum Pathol; 1991 Jul; 22(7):653-8. PubMed ID: 2071111 [TBL] [Abstract][Full Text] [Related]
52. Cyanidanol: will a hepatotrophic drug from Europe go west? Hepatology; 1983; 3(1):121-3. PubMed ID: 6822375 [No Abstract] [Full Text] [Related]
53. Hepatoprotective agents in alcoholic liver disease. Morgan MY Acta Med Scand Suppl; 1985; 703():225-33. PubMed ID: 3937442 [No Abstract] [Full Text] [Related]
54. [The progress of precision-cut liver slice in the study liver fibrosis]. An JY; Chen XL; Zhang XL Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):949-51. PubMed ID: 22553805 [No Abstract] [Full Text] [Related]